These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8158288)

  • 21. Cephalexin concentrations in radicular granuloma following a single oral administration of 250- or 500-mg cephalexin.
    Akimoto Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kawana T; Kaneko K; Fujii A; Kaneda T
    Gen Pharmacol; 1994 Dec; 25(8):1563-6. PubMed ID: 7721029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics of norfloxacin and lomefloxacin in aqueous humour analysed by microdialysis].
    Sato H; Fukuda S; Inatomi M; Koide R; Uchida N; Kanda Y; Kiuchi Y; Oguchi K
    Nippon Ganka Gakkai Zasshi; 1996 Jul; 100(7):513-9. PubMed ID: 8741334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
    Nilsen OG; Saltvedt E; Walstad RA; Marstein S
    Am J Med; 1992 Apr; 92(4A):38S-40S. PubMed ID: 1316068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose].
    Guibert J; Kitzis MD; Acar JF; Masquelier AM; Bellanger B
    Pathol Biol (Paris); 1989 May; 37(5):411-4. PubMed ID: 2506515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
    Kovarik JM; Hoepelman AI; Smit JM; Sips PA; Rozenberg-Arska M; Glerum JH; Verhoef J
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2458-61. PubMed ID: 1336948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial activity of lomefloxacin.
    Leigh DA; Tait S; Walsh B
    J Antimicrob Chemother; 1991 May; 27(5):589-98. PubMed ID: 1885417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
    Morrison PJ; Mant TG; Norman GT; Robinson J; Kunka RL
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1503-7. PubMed ID: 3214495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lomefloxacin clinical pharmacokinetics.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    Clin Pharmacokinet; 1993 Jul; 25(1):6-19. PubMed ID: 8394795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
    Perea EJ; García I; Pascual A
    Am J Med; 1992 Apr; 92(4A):48S-51S. PubMed ID: 1316071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and safety of single oral doses of lomefloxacin.
    Morse IS
    Biopharm Drug Dispos; 1990; 11(6):543-51. PubMed ID: 2207304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.
    Giguère S; Sweeney RW; Bélanger M
    Am J Vet Res; 1996 Jul; 57(7):1025-30. PubMed ID: 8807015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Penetration into bone and joint tissues of rabbits and in vitro antibacterial activity of tosufloxacin].
    Yamashiro Y; Nunome M; Takahata M; Yasuda T
    Jpn J Antibiot; 1993 Jan; 46(1):31-5. PubMed ID: 8384277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefaclor concentrations in human serum, gingiva, mandibular bone, and dental follicle following a single oral administration.
    Akimoto Y; Mochizuki Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kaneko K; Fujii A
    Gen Pharmacol; 1992 Jul; 23(4):639-42. PubMed ID: 1397970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High IL-6 synthesis in cultured fibroblasts isolated from radicular cysts.
    Kusumi A; Sakaki H; Fukui R; Satoh H; Kusumi T; Kimura H
    Arch Oral Biol; 2004 Aug; 49(8):643-52. PubMed ID: 15196982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
    Wijnands GJ; Cornel JH; Martea M; Vree TB
    Chest; 1990 Dec; 98(6):1440-4. PubMed ID: 2245687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
    Mant TG
    Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraprostatic distribution of lomefloxacin following multiple-dose administration.
    Kovarik JM; de Hond JA; Hoepelman IM; Boon T; Verhoef J
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2398-401. PubMed ID: 2088193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular distribution of lomefloxacin 0.3% after a single instillation in the infected eye of pigmented rabbits.
    Elena PP; Jauch A
    J Ocul Pharmacol Ther; 1997 Dec; 13(6):551-8. PubMed ID: 9436158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and relative bioavailability of lomefloxacin preparations in 10 healthy Chinese volunteers.
    Diao Y; Lu J; Li L; Zhu XD; Ji G; Wang EH
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):247-9. PubMed ID: 8237402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.